NQO1 and cancer: Since NQO1 and GSTP1 are phase-II detoxification enzymes that reduce quinones directly to hydroquinones, eliminating the formation of ROS produced by redox cycling [21], the combination of inhibition of NQO1 and GSTP1 may offer a potential solution for cancer therapy.